| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ab8d5e4558668a6dd1124fec4302976 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
| filingDate |
2000-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93322d0032b12a47a8e36ade991bdc5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1375c2c2ccdc2b4b0ea5fd7813130060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51bcba107e7d6680c34e61749481d922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_943c719f165a4160e2b1f1229bfeec1a |
| publicationDate |
2001-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20010100197-A |
| titleOfInvention |
Process for producing clarithromycin using erythromycin a 9-o-tropyloxime derivatives |
| abstract |
The present invention relates to an improved method for the simple production of macrolide antibiotic clarithromycin in high yield using an erythromycin A 9- O -trophiloxime derivative of the formula (2).n n n n n n n n n n Wheren n n R 1 is hydrogen or a methyl group, R 2 is hydrogen or trimethylsilyl group, provided that when R 1 is a methyl group, R 2 is trimethylsilyl group. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004007518-A1 |
| priorityDate |
2000-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |